$36.41
-1.03-2.75%
Pre-Market: 4:16 AM EDT
15 minutes delayed
Comments
Loading...
Structure Therapeutics
GPCRNASDAQ
Structure Therapeutics (GPCR) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestStructure Therapeutics (NASDAQ:GPCR) Stock Quotes, Forecast and News Summary
Structure Therapeutics Stock (NASDAQ: GPCR) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 232.00 / 1.14M |
| Day Range | - - - |
| 52 Wk Range | 25.57 - 75.02 |
| Market Cap | $2.08B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 38 |
| Short Interest | 19.35% |
| Days to Cover | 8.48 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Structure Therapeutics Inc
Sector
Health Care
Industry
Pharmaceuticals
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliv...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Structure Therapeutics (GPCR) stock?
You can purchase shares of Structure Therapeutics (NASDAQ:GPCR) through any online brokerage.
Who are Structure Therapeutics (GPCR) competitors?
Other companies in Structure Therapeutics’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Neumora Therapeutics (NASDAQ:NMRA), ANI Pharmaceuticals (NASDAQ:ANIP) and Longboard Pharmaceuticals (NASDAQ:LBPH).
What is the target price for Structure Therapeutics (GPCR) stock?
There is no analysis for Structure Therapeutics.
What is the forecast for Structure Therapeutics (GPCR) stock?
Structure Therapeutics has a consensus price target of $72.88.
Current stock price for Structure Therapeutics (GPCR)?
The stock price for Structure Therapeutics (NASDAQ: GPCR) is $36.41 last updated Today at July 22, 2024 at 4:16 AM EDT.
Does Structure Therapeutics (GPCR) pay a dividend?
There are no upcoming dividends for Structure Therapeutics.
When is Structure Therapeutics (NASDAQ:GPCR) reporting earnings?
Structure Therapeutics’s Q2 earnings are confirmed for Wednesday, August 14, 2024.
Is Structure Therapeutics (GPCR) going to split?
There is no upcoming split for Structure Therapeutics.
What sector and industry does Structure Therapeutics (GPCR) operate in?
Structure Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.